Published in J Clin Microbiol on December 01, 2000
Application of molecular techniques to the study of hospital infection. Clin Microbiol Rev (2006) 1.57
Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam. J Clin Microbiol (2002) 0.94
Molecular epidemiology of penicillin-susceptible non-beta-lactam-resistant Streptococcus pneumoniae isolates from Greek children. J Clin Microbiol (2003) 0.88
Molecular characterization of non-penicillin-susceptible Streptococcus pneumoniae in Norway. J Clin Microbiol (2006) 0.85
Low incidence of antibiotic resistance among invasive and nasopharyngeal isolates of Streptococcus pneumoniae from children in rural Philippines between 1994 and 2000. Eur J Clin Microbiol Infect Dis (2008) 0.79
Phenotypic and genotypic characterization of invasive Streptococcus pneumoniae clinical isolates. Curr Ther Res Clin Exp (2004) 0.78
Rapidly increasing prevalence of penicillin-resistant Streptococcus pneumoniae in middle Tennessee: a 10-year clinical and molecular analysis. J Clin Microbiol (2002) 0.77
Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco. Ann Clin Microbiol Antimicrob (2017) 0.75
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J (2000) 11.94
Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (1997) 7.36
Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis (1991) 6.69
Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol Microbiol (1991) 5.45
Extensive re-modelling of the transpeptidase domain of penicillin-binding protein 2B of a penicillin-resistant South African isolate of Streptococcus pneumoniae. Mol Microbiol (1989) 4.78
Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis (1993) 3.94
Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob Agents Chemother (1992) 3.39
Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J Infect Dis (1997) 3.11
The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis (1992) 3.04
Genetic relationships of penicillin-susceptible and -resistant Streptococcus pneumoniae strains isolated on different continents. Infect Immun (1992) 2.62
Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States. Microb Drug Resist (1998) 2.62
An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med (1998) 2.56
Comparative study of five different DNA fingerprint techniques for molecular typing of Streptococcus pneumoniae strains. J Clin Microbiol (1995) 2.55
Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. Pediatr Infect Dis J (1999) 2.52
Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens. Antimicrob Agents Chemother (1999) 2.33
Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns. J Clin Microbiol (1996) 2.32
Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr (1996) 2.17
Molecular epidemiology of drug-resistant pneumococci: toward an international approach. Microb Drug Resist (1997) 2.03
Novel BOX repeat PCR assay for high-resolution typing of Streptococcus pneumoniae strains. J Clin Microbiol (1996) 2.00
Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Pediatr Infect Dis J (1999) 1.81
Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. Microbiology (1996) 1.69
Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis (2000) 1.69
Novel penicillin-resistant clones of Streptococcus pneumoniae in the Czech Republic and in Slovakia. Microb Drug Resist (1995) 1.56
Molecular epidemiologic characterization of penicillin-resistant Streptococcus pneumoniae invasive pediatric isolates recovered in six Latin-American countries: an overview. PAHO/Rockefeller University Workshop. Pan American Health Organization. Microb Drug Resist (1998) 1.54
Penicillin-resistant Streptococcus pneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey. J Infect Dis (1997) 1.51
Three predominant clones identified within penicillin-resistant South African isolates of Streptococcus pneumoniae. Microb Drug Resist (1997) 1.45
Molecular characterization of pneumococcal nasopharynx isolates collected from children during their first 2 years of life. J Clin Microbiol (1998) 1.40
Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolates recovered in Italy from 1993 to 1996. J Clin Microbiol (1998) 1.38
Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Toronto Child Care Centre Study Group. Arch Pediatr Adolesc Med (1999) 1.30
Carriage of antibiotic-resistant Streptococcus pneumoniae by children in eastern and central Europe--a multicenter study with use of standardized methods. Clin Infect Dis (1996) 1.29
Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children. Eur J Clin Microbiol Infect Dis (1998) 1.27
Relatedness of penicillin-resistant Streptococcus pneumoniae serogroup 9 strains from France and Spain. Microbiology (1995) 1.27
Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J (1998) 1.22
Resistance patterns of streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece. Clin Infect Dis (1997) 1.19
Genotypic survey of recent beta-lactam-resistant pneumococcal nasopharyngeal isolates from asymptomatic children in Chile. J Clin Microbiol (1999) 1.14
Epidemiology of penicillin resistant pneumococci in Iceland. Microb Drug Resist (1995) 1.12
beta-lactam-resistant Streptococcus pneumoniae: epidemiology and evolutionary mechanism. Chemotherapy (1999) 1.12
Multiple antimicrobial resistance of pneumococci in children with otitis media, bacteremia, and meningitis in Slovakia. J Infect Dis (1995) 1.08
Genomic DNA fingerprinting by restriction fragment end labeling. Proc Natl Acad Sci U S A (1995) 1.04
Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. Vaccine (2000) 0.96
Molecular epidemiological survey of penicillin-resistant Streptococcus pneumoniae from Asia, Europe, and North America. Diagn Microbiol Infect Dis (1999) 0.91
Carriage of antibiotic-resistant Streptococcus pneumoniae in Greek infants and toddlers. Eur J Clin Microbiol Infect Dis (2000) 0.91
Genetic analysis of serotype 23F Streptococcus pneumoniae isolates from several countries by penicillin-binding protein gene fingerprinting and pulsed-field gel electrophoresis. Chemotherapy (1999) 0.84
Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol (1991) 19.65
A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med (2001) 16.32
Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol (1999) 11.63
Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol (1993) 11.24
Characterization of a Mycobacterium tuberculosis insertion sequence belonging to the IS3 family. Mol Microbiol (1990) 10.36
Detection of Mycobacterium tuberculosis in clinical samples by using polymerase chain reaction and a nonradioactive detection system. J Clin Microbiol (1992) 6.08
A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol (1997) 5.28
DNA fingerprinting of Mycobacterium tuberculosis. Methods Enzymol (1994) 4.60
Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet (2004) 4.39
Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med (1988) 4.17
Insertion element IS1081-associated restriction fragment length polymorphisms in Mycobacterium tuberculosis complex species: a reliable tool for recognizing Mycobacterium bovis BCG. J Clin Microbiol (1992) 3.99
Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosis. J Clin Microbiol (1994) 3.96
Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr (1997) 3.80
Mycobacterial protein antigens: a compilation. Mol Microbiol (1992) 3.35
Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect Immun (2000) 2.91
[Chickenpox: sufficient reasons for the introduction of vaccination]. Ned Tijdschr Geneeskd (2006) 2.61
Comparative study of five different DNA fingerprint techniques for molecular typing of Streptococcus pneumoniae strains. J Clin Microbiol (1995) 2.55
Treponema pallidum subspecies pallidum (Nichols) and Treponema pallidum subspecies pertenue (CDC 2575) differ in at least one nucleotide: comparison of two homologous antigens. Microb Pathog (1989) 2.21
No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine (2004) 2.13
Molecular epidemiology of drug-resistant pneumococci: toward an international approach. Microb Drug Resist (1997) 2.03
Use of recombinant antigens expressed in Escherichia coli K-12 to map B-cell and T-cell epitopes on the immunodominant 65-kilodalton protein of Mycobacterium bovis BCG. Infect Immun (1988) 2.01
Novel BOX repeat PCR assay for high-resolution typing of Streptococcus pneumoniae strains. J Clin Microbiol (1996) 2.00
Influenza types and patient population. Lancet (1995) 1.94
Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. J Infect Dis (1999) 1.87
Genetic markers for the epidemiology of tuberculosis. Res Microbiol (1992) 1.80
Pneumococcal vaccines: an update on current strategies. Vaccine (2004) 1.69
Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis (2003) 1.59
Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol (2000) 1.58
Penicillin-resistant Streptococcus pneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey. J Infect Dis (1997) 1.51
Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece. Antimicrob Agents Chemother (2001) 1.50
Pathophysiology of meningococcal sepsis in children. Eur J Pediatr (1998) 1.46
Validation of 70-gene prognosis signature in node-negative breast cancer. Breast Cancer Res Treat (2008) 1.45
Molecular characterization of pneumococcal nasopharynx isolates collected from children during their first 2 years of life. J Clin Microbiol (1998) 1.40
[Osteomyelitis as a complication following BCG vaccination]. Ned Tijdschr Geneeskd (1995) 1.39
Epidemiology of tuberculosis by DNA fingerprinting. Eur Respir J Suppl (1995) 1.37
Differential protein expression in phenotypic variants of Streptococcus pneumoniae. Infect Immun (2000) 1.32
Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur J Pediatr (2001) 1.31
Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age. Vaccine (2000) 1.31
Use of pooled urine samples and automated DNA isolation to achieve improved sensitivity and cost-effectiveness of large-scale testing for Chlamydia trachomatis in pregnant women. J Clin Microbiol (2005) 1.31
Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study. J Clin Microbiol (2001) 1.29
Persistence of clones of coagulase-negative staphylococci among premature neonates in neonatal intensive care units: two-center study of bacterial genotyping and patient risk factors. J Clin Microbiol (1998) 1.29
The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses. Infect Immun (2000) 1.28
4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet (1999) 1.28
Mycobacteria contain two groEL genes: the second Mycobacterium leprae groEL gene is arranged in an operon with groES. Mol Microbiol (1992) 1.28
Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine. Infect Immun (2002) 1.21
64Cu metabolism in Menkes and normal cultured skin fibroblasts. Pediatr Res (1978) 1.21
Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments. Vaccine (2006) 1.20
Host-mediated modification of PvuII restriction in Mycobacterium tuberculosis. J Bacteriol (1996) 1.20
Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet (2007) 1.20
Characterization of the molecular defect in infantile and adult acid alpha-glucosidase deficiency fibroblasts. J Clin Invest (1978) 1.19
Resistance patterns of streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece. Clin Infect Dis (1997) 1.19
The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease. Infect Immun (2004) 1.17
Multidrug-resistant Streptococcus pneumoniae in Poland: identification of emerging clones. J Clin Microbiol (1999) 1.15
Risk factors for respiratory syncytial virus associated apnoea. Eur J Pediatr (1998) 1.15
Dexamethasone in the treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis (1987) 1.14
Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and the esterification of cholesterol in human long term lymphoid cell lines. Biochemistry (1976) 1.14
Ocular abnormalities in patients with beta thalassemia. Am J Ophthalmol (1989) 1.14
Relationship between clinical severity of respiratory syncytial virus infection and subtype. Arch Dis Child (1996) 1.14
Arylsulfatase B deficiency in Maroteaux-Lamy syndrome: Cellular studies and carrier identification. Pediatr Res (1975) 1.13
Letter: Genetic heterogeneity in fucosidosis. Lancet (1973) 1.13
Age-dependent pharmacokinetics of lamivudine in HIV-infected children. Clin Pharmacol Ther (2007) 1.10
The role of nitric oxide in bacterial meningitis in children. J Infect Dis (1996) 1.10
Familial de Lange syndrome. Report of three cases in a sibship. Clin Genet (1971) 1.09
Polymorphism of human alpha fucosidase. Am J Hum Genet (1975) 1.09
Isozymes of human alpha-L-fucosidase detectable by starch gel electrophoresis. Clin Chim Acta (1974) 1.09
[Epidemiological characteristics of reported HIV-1 infection in children in the Netherlands, 1998-2000: vertical transmission via parents from countries with a generalised epidemic]. Ned Tijdschr Geneeskd (2002) 1.08
Reviewing Omenn syndrome. Eur J Pediatr (2001) 1.07
The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis (1996) 1.06
[Reduction of vertical transmission by means of perinatal prophylaxis in the case of children exposed to HIV-1 and born in the Netherlands during the period 1995-1999]. Ned Tijdschr Geneeskd (2002) 1.06
Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults. J Infect Dis (2001) 1.06
Longitudinal survey of lymphocyte subpopulations in the first year of life. Pediatr Res (2000) 1.05
Dynamics of pneumococcal colonization in healthy Dutch children. Microbiology (2006) 1.05
Letter: Severe combined immunodeficiency and adenosine-deaminase deficiency. Lancet (1973) 1.04
Genomic DNA fingerprinting by restriction fragment end labeling. Proc Natl Acad Sci U S A (1995) 1.04
Induction of meningeal inflammation by outer membrane vesicles of Haemophilus influenzae type b. J Infect Dis (1989) 1.04
Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis (1995) 1.03
Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review. Acta Paediatr (2000) 1.03
Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score. Clin Infect Dis (1997) 1.03
Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis. Infect Immun (1997) 1.03
Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant. Pediatr Res (1994) 1.03
Retinal vasculitis occurring with common variable immunodeficiency syndrome. Am J Ophthalmol (2000) 1.02
Long-term lymphoid cell lines in the study of human genetics. Prog Med Genet (1976) 1.01
Cell-specific differences in membrane beta-glucosidase from normal and Gaucher cells. Biochim Biophys Acta (1977) 1.01
Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J (1997) 1.01
Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine. Vaccine (2001) 1.00
Increased levels and positive correlation between erythropoietin and hemoglobin concentrations in newborn children of mothers who are smokers. J Pediatr (1994) 1.00
Genetic heterogeneity in acid alpha-glucosidase deficiency. Am J Hum Genet (1983) 1.00
Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine. Infect Immun (2003) 0.98
Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients. Lancet (2001) 0.98